The promise of liquid biopsies in prostate cancer: a potential point-of-care modality for precision oncology.

INTRODUCTION: Blood-based liquid biopsies represent a transformative, minimally-invasive, and patient-friendly approach. Tumor-derived components in the bloodstream, are at the forefront of active research for diagnosis and prediction of prognosis. E…

Preview only. Read the full abstract at the source